Old Lyme, CT, United States of America

Thomas K Schaaf


Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 197(Granted Patents)


Location History:

  • New London, CT (US) (1976 - 1977)
  • Old Lyme, CT (US) (1976 - 1984)

Company Filing History:


Years Active: 1976-1984

Loading Chart...
35 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Thomas K. Schaaf in Prostaglandin Research**

Introduction

Thomas K. Schaaf, an accomplished inventor based in Old Lyme, CT, has made significant contributions to the field of prostaglandin research. With an impressive portfolio of 35 patents, Schaaf has focused on developing novel compounds that demonstrate therapeutic advantages over existing treatments. His work is characterized by a commitment to enhancing tissue specificity and efficacy in drug development.

Latest Patents

Among his latest patents, Schaaf has developed compounds such as 11-Desoxy-16-aryloxy-.omega.-tetranorprostaglandins. These innovative prostaglandins showcase activity profiles comparable to their parent compounds while exhibiting greater tissue specificity. Another noteworthy patent includes the 15-Substituted-.omega.-pentanorprostaglandin derivatives, which encompass C-1 tetrazoles, imides, and sulfonimides. These derivatives have demonstrated potential as anti-secretory agents as well as tools for fertility control.

Career Highlights

Schaaf's career has been marked by his role as a key researcher at Pfizer Corporation, one of the leading pharmaceutical companies in the world. His innovative approach has facilitated advancements in prostaglandin-related therapies, contributing to the scientific community's understanding of these important bioactive lipids.

Collaborations

Throughout his career, Schaaf has collaborated with esteemed colleagues, including Hans-Jurgen E. Hess and Jasjit S. Bindra. These partnerships have fostered a multidisciplinary approach to research and development, which is essential in a rapidly evolving field like pharmaceuticals.

Conclusion

Thomas K. Schaaf's contributions to the field of prostaglandins underscore the importance of innovation in healthcare. His latest patents not only enhance the understanding of prostaglandin functionality but also pave the way for future research and therapeutic options. As he continues his work at Pfizer Corporation, Schaaf remains a significant figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…